<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is the second cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:hpo ids='HP_0011420'>death</z:hpo> in the Western world </plain></SENT>
<SENT sid="1" pm="."><plain>Much of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> genetic risk remains unidentified and may be attributable to a large number of common, low-penetrance genetic variants </plain></SENT>
<SENT sid="2" pm="."><plain>Genetic linkage studies in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> families have reported additional association with regions 9q22-31, 3q21-24, 7q31, 11q, 14q and 22q </plain></SENT>
<SENT sid="3" pm="."><plain>There are several plausible candidate genes for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> susceptibility within the aforementioned linkage regions including PTCH1, <z:e sem="disease" ids="C0268135" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">XPA</z:e> and TGFBR1 in 9q22-31, and EPHB1 and MRAS in 3q21-q24 </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cases and matched controls were from EPICOLON, a prospective, multicentre, nationwide Spanish initiative, composed of two independent phases </plain></SENT>
<SENT sid="5" pm="."><plain>Phase 1 corresponded to 515 CRC cases and 515 controls, whereas phase 2 consisted of 901 CRC cases and 909 controls </plain></SENT>
<SENT sid="6" pm="."><plain>Genotyping was performed for 172 single-nucleotide polymorphisms (SNPs) in 84 genes located within regions 9q22-31 and 3q21-q24 </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: None of the 172 SNPs analysed in our study could be formally associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk </plain></SENT>
<SENT sid="8" pm="."><plain>However, rs1444601 (TOPBP1) and rs13088006 (CDV3) in region 3q22 showed interesting results and may have an effect on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: TOPBP1 and CDV3 genetic variants on region 3q22 may modulate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk </plain></SENT>
<SENT sid="10" pm="."><plain>Further validation and meta-analysis should be undertaken in larger <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cohorts </plain></SENT>
</text></document>